Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 3,559 | 52,480 | 42,141 | 12,514 | 5,285 |
| Gross Profit | 3,559 | 52,480 | 42,141 | 12,514 | 5,285 |
| Operating Expenses | 111,045 | 113,896 | 108,639 | 89,635 | 90,878 |
| Operating Income | -107,486 | -61,416 | -66,498 | -77,121 | -85,593 |
| Other Income | 4,187 | 2,649 | 1,278 | 1,285 | 1,005 |
| Pre-tax Income | -103,299 | -58,767 | -65,220 | -75,836 | -84,588 |
| Income Tax | N/A | 27 | N/A | N/A | N/A |
| Net Income Continuous | -103,299 | -58,794 | -65,220 | -75,261 | -84,588 |
| Net Income | $-103,299 | $-58,794 | $-65,220 | $-75,261 | $-84,588 |
| EPS Basic Total Ops | -0.84 | -0.48 | -0.53 | -0.62 | -0.69 |
| EPS Basic Continuous Ops | -0.84 | -0.48 | -0.53 | -0.62 | -0.69 |
| EPS Diluted Total Ops | -0.84 | -0.48 | -0.53 | -0.62 | -0.69 |
| EPS Diluted Continuous Ops | -0.84 | -0.48 | -0.53 | -0.62 | -0.69 |
| EBITDA(a) | $-106,033 | $-58,853 | $-62,792 | $-72,595 | $-80,746 |